RIO DE JANEIRO (Sputnik) – The Brazilian foreign and health ministries are willing to continue the conversation about Russia’s coronavirus vaccine Sputnik V so it can be authorised for use in the country.
“[The foreign and health ministries are willing] to support the current dialogue, while respecting the autonomy of Anvisa, so that Sputnik V will strengthen the country’s national coronavirus vaccination programme after it is approved in Brazil”, the ministries said in a joint statement.
The ministries have also noted the readiness of Anvisa, the RDIF, and the Gamaleya Institute, the vaccine’s developer, to clarify the remaining issues, including providing additional documents.
Last week, the Brazilian health regulator Anvisa rejected a regional government request to import the Russian-made vaccine. The Russian Direct Investment Fund (RDIF), which markets Sputnik V abroad, said it believes the decision may be “politically motivated”, citing a US Department of Health report that the United States had attempted to persuade Brazil not to use the vaccine.